Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHOSPHATE Trial: Intensive vs Liberal Phosphate Target in ESKD
NCT03573089Recruiting
- Sponsor
- The University of Queensland
- Start
- Dec 2019
- Primary completion
- Dec 2027
- Countries
- 9
01
Overview
Randomised, open-label trial in hyperphosphatemia (2 arms), sponsored by The University of Queensland. Primary endpoint: Major Adverse Cardiovascular Events at 5 years. Started Dec 2019; status: recruiting.
02
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT03573089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03573089.